<DOC>
	<DOCNO>NCT02406599</DOCNO>
	<brief_summary>The study objective determine MarginProbe® System 's diagnostic accuracy margin level impact Positive Margin* Presence originate Main ex-vivo lumpectomy specimen initial lumpectomy surgery . *A positive margin define study margin microscopically measure report histology report cancer within 1 mm less inked surface</brief_summary>
	<brief_title>MarginProbe® System U.S. Post-Approval Study</brief_title>
	<detailed_description>This prospective , multicenter , randomize ( 1:1 ) , double arm , control study , subject undergoing breast excision ( lumpectomy ) carcinoma breast randomize either standard care additional inspection ( 'SOC + Additional inspection ' arm ) standard care MarginProbe adjunct ( 'SOC + Device ' arm ) . The MarginProbe adjunctive diagnostic tool identification cancerous tissue margin ( ≤ 1mm ) main ex-vivo lumpectomy specimen follow primary excision . It use surgeon lumpectomy procedure patient randomize `` Device+SOC '' arm . Randomization take place follow excision main ex-vivo lumpectomy specimen .</detailed_description>
	<criteria>Women histologically diagnose carcinoma breast Women nonpalpable malignant lesion , require image guide localization . Undergoing lumpectomy ( partial mastectomy ) procedure Age 18 year Signed ICF Multicentric disease ( histologically diagnose cancer two different quadrant breast ) Bilateral disease ( diagnosed cancer breast ) Neoadjuvant systemic therapy Previous radiation operate breast Prior surgery site breast Woman histologically diagnose open biopsy procedure Implants operate breast Pregnancy Lactation Participating investigational study either drug device could influence collection valid data study Patients complete cavity shaving plan ( site routine practice investigator also exclude participation study )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>